Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arthritis Treatment Centers of America (ATCA) is a specialized healthcare provider network focused on the diagnosis and advanced treatment of rheumatic and inflammatory diseases. The organization operates multiple state-of-the-art clinics, primarily in Florida, offering comprehensive services including rheumatology consultations, diagnostic imaging, and on-site infusion therapy. ATCA specializes in the administration of biologic medications and small molecule therapies for chronic conditions such as rheumatoid arthritis, lupus, and psoriatic arthritis. By integrating clinical expertise with specialized pharmacy services, the centers provide a streamlined care model for patients requiring complex therapeutic regimens. Additionally, ATCA participates in clinical research trials, providing patients with access to emerging treatments in the field of immunology and rheumatology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arthritis Treatment Centers of America.